Core Viewpoint - Dabo Medical's stock closed at 32.78 yuan on April 28, experiencing a decline of 2.38%, with a rolling PE ratio of 38.04 times and a total market capitalization of 13.572 billion yuan [1] Group 1: Company Performance - Dabo Medical reported a revenue of 2.136 billion yuan for the year 2024, representing a year-on-year increase of 39.29% [1] - The net profit for the same period was 357 million yuan, showing a significant year-on-year growth of 505.16% [1] - The company's gross profit margin stood at 68.75% [1] Group 2: Market Position - In the medical device industry, the average PE ratio is 46.40 times, while the median is 34.81 times, placing Dabo Medical at the 81st position in terms of PE ratio [2] - The company has seen a net inflow of 7.6753 million yuan in principal funds on April 28, with a total inflow of 2.9701 million yuan over the past five days [1]
大博医疗收盘下跌2.38%,滚动市盈率38.04倍,总市值135.72亿元